These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15570926)

  • 1. [Clinical problems in gemcitabine treatment for unresectable pancreatic cancer in the elderly--a multicentric retrospective study of 53 cases].
    Takeuchi N; Maejima S; Hasebe O; Matsuda Y; Hanazaki K; Kajikawa S; Mukawa K; Hosokawa K; Hayashi K; Hisa T; Furut K; Tajiri K; Fujimori Y; Kaneko G; Ochi Y; Shikama N; Kawa S; Miyagawa S; Miwa S; Kiyosawa K
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1987-91. PubMed ID: 15570926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of low-dose gemcitabine on unresectable pancreatic cancer in elderly patients.
    Matsumoto K; Miyake Y; Kato H; Kawamoto H; Imagawa A; Toyokawa T; Nakatsu M; Ando M; Hirohata M; Yamamoto K
    Digestion; 2011; 84(3):230-5. PubMed ID: 21860243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gemcitabine in elderly patients with unresectable pancreas cancer].
    Hanada K; Hino F; Amano H; Ooe H; Hirota Y; Sasao S; Obayashi M; Kajiyama G
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2521-5. PubMed ID: 12506475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine doublets in advanced pancreatic cancer: should we move on?
    Rocha Lima CM; Flores AM
    J Clin Oncol; 2006 Jan; 24(3):327-9. PubMed ID: 16344312
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcomes and tolerability of systemic chemotherapy for pancreatic or biliary cancer patients aged 75 years or older.
    Yukisawa S; Ishii H; Matsuyama M; Kuraoka K; Takano K; Kamei A; Ozaka M
    Jpn J Clin Oncol; 2011 Jan; 41(1):76-80. PubMed ID: 20926412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multi-center trial of gemcitabine for 49 patients with advanced pancreatic cancer].
    Sumii T; Funakoshi A; Ito T; Mizumoto K; Tanaka M; Migita Y; Sakai T; Shinozaki H; Yamaguchi H; Niyahara T; Muranaka T; Eriguchi N; Ueki T;
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):971-6. PubMed ID: 12894712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer.
    Ikeda M; Okada S; Tokuuye K; Ueno H; Okusaka T
    Br J Cancer; 2002 May; 86(10):1551-4. PubMed ID: 12085203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Outcomes of treatment with gemcitabine for unresectable pancreatic cancer].
    Nobutani K; Kutsumi H; Funatsu E; Nishida K; Ikezawa S; Shiomi H; Fukiya E; Suzuki T; Masuda K; Hata K; Nakamura H; Okuyama Y; Kimura H; Yagi N; Sugeta N; Yashiro H; Otsuka H; Suyama Y; Fujimoto S
    Gan To Kagaku Ryoho; 2004 Feb; 31(2):199-203. PubMed ID: 14997751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and effectiveness of gemcitabine in 855 patients with pancreatic cancer under Japanese clinical practice based on post-marketing surveillance in Japan.
    Ioka T; Katayama K; Tanaka S; Takakura R; Ashida R; Kobayashi N; Taniai H
    Jpn J Clin Oncol; 2013 Feb; 43(2):139-45. PubMed ID: 23275642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine as first-line chemotherapy in elderly patients with unresectable pancreatic carcinoma.
    Yamagishi Y; Higuchi H; Izumiya M; Sakai G; Iizuka H; Nakamura S; Adachi M; Hozawa S; Takaishi H; Hibi T
    J Gastroenterol; 2010 Nov; 45(11):1146-54. PubMed ID: 20549255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of gemcitabine, irinotecan, and celecoxib in patients with advanced pancreatic cancer.
    Lipton A; Campbell-Baird C; Witters L; Harvey H; Ali S
    J Clin Gastroenterol; 2010 Apr; 44(4):286-8. PubMed ID: 20216081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreas.
    Pipas JM; Mitchell SE; Barth RJ; Vera-Gimon R; Rathmann J; Meyer LP; Wagman RS; Lewis LD; McDonnell C; Colacchio TA; Perez RP
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1317-22. PubMed ID: 11483344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study of gemcitabine therapy for recurrent or metastatic pancreatic cancer].
    Moriwaki T; Hyodo I; Nishina T; Nasu J; Hidaka S; Kajiwara T; Tsuzuki T; Hirao K; Tsubouchi E; Yamauchi Y; Hirasaki S; Masumoto T; Tanada M
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1373-6. PubMed ID: 15446559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gemcitabine therapy for unresectable pancreatic cancer in elderly patients].
    Katakura Y; Nakahara K; Kobayashi M; Adachi S; Izawa N; Noguchi Y; Nakatsu S; Sato Y; Takagi R; Itoh F
    Nihon Shokakibyo Gakkai Zasshi; 2010 Mar; 107(3):396-406. PubMed ID: 20203443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Study Comparing the Effects of Targeted Intra-Arterial and Systemic Chemotherapy in an Orthotopic Mouse Model of Pancreatic Cancer.
    Rezaee M; Wang J; Razavi M; Ren G; Zheng F; Hussein A; Ullah M; Thakor AS
    Sci Rep; 2019 Nov; 9(1):15929. PubMed ID: 31685925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Concurrent chemoradiotherapy using full-dose gemcitabine for patients with unresectable pancreatic cancer].
    Yamazaki H; Nishiyama K; Koizumi M
    Nihon Igaku Hoshasen Gakkai Zasshi; 2004 May; 64(4):216-9. PubMed ID: 15211883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial.
    Loehrer PJ; Feng Y; Cardenes H; Wagner L; Brell JM; Cella D; Flynn P; Ramanathan RK; Crane CH; Alberts SR; Benson AB
    J Clin Oncol; 2011 Nov; 29(31):4105-12. PubMed ID: 21969502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemcitabine plus S-1: a hopeful frontline treatment for Asian patients with unresectable advanced pancreatic cancer.
    Cao C; Kuang M; Xu W; Zhang X; Chen J; Tang C
    Jpn J Clin Oncol; 2015 Dec; 45(12):1122-30. PubMed ID: 26518328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial].
    Barhoumi M; Mornex F; Bonnetain F; Rougier P; Mariette C; Bouché O; Bosset JF; Aparicio T; Mineur L; Azzedine A; Hammel P; Butel J; Stremsdoerfer N; Maingon P; Bedenne L; Chauffert B
    Cancer Radiother; 2011 Jun; 15(3):182-91. PubMed ID: 21315644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trial dosing of gemcitabine and concurrent involved field irradiation in patients with localized pancreatic carcinomas.
    Nanfro JJ
    J Clin Oncol; 1999 Nov; 17(11):3692. PubMed ID: 10550172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.